BMIAX
Price
$6.19
Change
+$0.02 (+0.32%)
Updated
Nov 18 closing price
Net Assets
125.58M
RWMHX
Price
$65.89
Change
-$0.23 (-0.35%)
Updated
Nov 18 closing price
Net Assets
204.42B
Interact to see
Advertisement

BMIAX vs RWMHX

Header iconBMIAX vs RWMHX Comparison
Open Charts BMIAX vs RWMHXBanner chart's image
BNY Mellon Income Stock A
Price$6.19
Change+$0.02 (+0.32%)
VolumeN/A
Net Assets125.58M
American Funds Washington Mutual R5E
Price$65.89
Change-$0.23 (-0.35%)
VolumeN/A
Net Assets204.42B
BMIAX vs RWMHX Comparison Chart in %
View a ticker or compare two or three
VS
BMIAX vs. RWMHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMIAX is a Hold and RWMHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMHX has more cash in the bank: 204B vs. BMIAX (126M). RWMHX pays higher dividends than BMIAX: RWMHX (1.33) vs BMIAX (1.06). BMIAX was incepted earlier than RWMHX: BMIAX (9 years) vs RWMHX (10 years). BMIAX (1.27) is less costly to investors than RWMHX (0.41). BMIAX is a more actively managed with annual turnover of: 92.12 vs. RWMHX (29.00). RWMHX has a lower initial minimum investment than BMIAX: RWMHX (250) vs BMIAX (1000). RWMHX annual gain was more profitable for investors over the last year : 3.91 vs. BMIAX (-27.58). RWMHX return over 5 years is better than : 43.18 vs. BMIAX (-18.81).
BMIAXRWMHXBMIAX / RWMHX
Total Expense Ratio1.150.41280%
Annual Report Gross Expense Ratio1.270.41310%
Fund Existence9 years10 years-
Gain YTD-8.5648.429-102%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets126M204B0%
Annual Yield % from dividends1.061.3380%
Returns for 1 year-27.583.91-706%
Returns for 3 years-31.9629.08-110%
Returns for 5 years-18.8143.18-44%
Returns for 10 yearsN/A71.17-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLAX39.53N/A
N/A
PGIM Jennison Health Sciences A
HAGIX79.17N/A
N/A
Carillon Eagle Mid Cap Growth I
EISGX16.06N/A
N/A
Eaton Vance Small-Cap I
EEMRX9.97N/A
N/A
MFS Emerging Markets Equity Research C
FEQHX14.79N/A
N/A
Fidelity Hedged Equity